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ABSTRACT
ALTERING NITRIC OXIDE BIOAVAILABILITY AND LIPID PROFILES IN
ENDOTHELIAL CELLS BY POLYCYCLIC AROMATIC HYDROCARBONS IN
PARTICULATE MATTER
Liang Yu
Old Dominion University, 2011
Co-Directors: Dr. R. James Swanson
Dr. H. Anna Jeng

Epidemiologic studies have demonstrated a significant association between
exposure to particulate matter (PM) and atherosclerosis. Polycyclic aromatic
hydrocarbons (PAHs) present in particulate matter, are well known to induce oxidative
stress and lipid peroxidation via generation of reactive oxygen species (ROS). Lipid
peroxidation involves regulating endothelial nitric oxide synthase via inhibition of its
activity, and as a result, mediates dilation of coronary arterioles is involved with the
pathogenesis of atherosclerosis. However, data on assessment of oxidized lipid
formation is limited due to low resolution of mass spectrometer methods. Taking the
advantage of a Fourier Transform Ion Cyclotron Resonance Mass Spectrometer (FT-ICRMS) with 12 Tesla at Old Dominion University, this study assessed how lipid
peroxidation induced by PAHs altered the lipid profile and nitric oxide level in human
endothelial cells.
Human coronary artery endothelial cells (HCAEC) were exposed to PAHs with
various doses and treatment duration times. After exposure, the level of ROS was
measured using the fluorometric method with a flow cytometer. Lipid peroxidation was
assessed based on the formation of malondialdehyde. Nitric oxide synthase was

calculated using a cell-permeable diacetate that reacts with NO to form a fluorescent
triazolofluorescein. Then, lipids of HCAEC were extracted by chloroform and methanol
and analyzed using 12T FT-ICR-MS to separate peaks.
After PAH exposure, cell morphology noticeably changed, granularity increased,
and viability decreased after the short term treatment. The ROS level, expressed as
fluorescent intensity readings from a flow cytometer, significantly increased along with
the malondialdehyde levels. The analysis of spectrum data from FT-ICR-MS showed
changes of the cellular lipid profile in the exposed groups as compared to the control.
We found no significant impacts of oxidative stress on nitric oxide bioavailability in
endothelial cells. However, direct exposure of HCAEC to PAHs increased lipid
oxidization. These data imply that PAHs may mediate nitric oxide synthase activity
through lipid peroxidation by a mechanism yet to be elucidated. These studies
demonstrate one potential means by which oxidative stress can induce endothelial cell
damage and lipid peroxidation during atherosclerosis for a short term exposure.
In conclusion, the oxidation pathway induced by PAHs contributed to endothelial
cell damage. This study identified lipids and developed novel data analytic approaches
that are applicable in revealing oxidative lipid formation induced by PAHs. In addition,
the technology enables us to identify specifically oxidized phospholipids that could serve
as biomarkers in assessing PAH-induced endothelial dysfunction and the underlying
mechanism.

Copyright, 2011, by Liang Yu, H. Anna Jeng and Dr. R. James Swanson, All
Rights Reserved.
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CHAPTER I
BACKGROUND, SPECIFIC AIMS, SIGNIFICANCE

BACKGROUND
Particulate Matters
Airborne PM is grouped with diameter sizes range from nanometers to 100 urn.
Particles between 10 and 2.5 um are classified as coarse (PMio), between 2.5 and 0.1 um
are classified as fine (PM2.5), less than 0.1 um are classified as ultrafme (UFP). Exposure
to PM is an important public health issue because of its association with cardiovascular
mortality and morbidity (Pope and Dockery 2006; Laden et al. 2006; Woodruff et al.
2008). Cardiovascular incidents from PM exposure have increased emergency room use
(Schwartz 1999, 2001). Also, the number of PM-associated deaths from cardiovascular
disease (CVD) equals or exceeds the number of such deaths from respiratory causes
(Peters et al. 1997). More recently, Miller and his colleagues found a 76% increase in
cardiovascular mortality for every 10 ug/m3 rise in the annual average of airborne fine
particulate matter (Miller et al. 2007). Chronic exposure to PM2.5 and UFPs increased the
severity of atherosclerotic aortic lesions in Watanabe rabbits and apolipoprotein (apo) Enull mice (Chen and Nadziejko 2005; Sun et al. 2005). In human studies involving 798
residents of the Los Angeles basin, Kunzli et al. found a 5.9% increase in the carotid
artery intima-media thickness per 10 ug/m increase in ambient PM2.5 (Kunzli et al.
2005).
Some studies showed that the toxicity and the carcinogenicity of PM are related to
their size, represent their capabilities to penetrate into the gas-exchange region of the
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lungs (Brown et al. 2001). Churg and co-workers found that the adverse health effects
appear to correlate better with PM2 5 than with PMio concentration (Churg and Brauer
2000). Moreover, electron microscopy analysis showed that 96% of the effectively
retained particles in the lung parenchyma were PM2 5, while only 5% were ultrafine
particles (Churg and Brauer 1997). A study, investigating the association between air
pollution and cardiorespiratory health during the winter of 1998-1999 in Amsterdam, the
Netherlands, concluded that PM2 5 was more strongly related to cardiorespiratory
symptoms than PMio and ultrafine particles were (de Hartog et al. 2003).
The importance of the effects of smaller particles on health is recognized by
scientific and regulatory communities. The Environmental Protection Agency (EPA)
initiated routine monitoring of PM2 5 and established new standards for PM2 5 under the
national ambient air quality standards (NAAQS) in 1997 (EPA 1997). Furthermore, a
recent World Health Organization report from panel studies suggested that fine particles
(<2.5 um) are more hazardous than coarse particles in terms of mortality and
cardiovascular endpoints. More importantly, additional research is needed to establish
the link between ultrafine PM exposure and risks to health in a more accurate and precise
manner (WHO 2003).
To date, there is limited data elucidating biological mechanisms between PM2 5
exposure and acute events of cardiovascular disease. Thus, this proposed study's aim is
to confirm the toxicity effects of PM2 5 and assess whether polycyclic aromatic
hydrocarbons (PAHs) is a major component contribute to cytotoxicity in endothelium in
relation to pathogenesis of cardiovascular disease.
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Polycyclic Aromatic Hydrocarbons
The use of diesel engine powered vehicles has been increasing in all over the
world with an increased need for transportation, and hence proportional higher indexes of
air pollution (Sydbom et al. 2001). Diesel engines emit more nitrogen oxides and
particles than gasoline engines though they offer better fuel efficiency and lower
emissions of carbon dioxide (Hesterberg et al. 2006). Fuel combustion and diesel engine
powered vehicle are the primary source for PM. The respirable diesel exhaust particles
(DEP) provide a good absorption surface for incomplete combustion derivatives of diesel
engines, on which an estimated 18000 different organic compounds such as PAHs, nitro
aromatic hydrocarbons, heteocyclics, quinones, aldehydes, and aliphatic hydrocarbons
(Salvi and Holgate 1999; Bai et al. 2001). Among them, article-bound PAHs are one of
major chemical components of PM and have been evaluated as potential carcinogens and
mutagens and precipitate the development of several diseases (Kavouras and Stephanou
2002).
PAHs are a group of over 100 different chemicals. Pure PAHs usually exist as
colorless, white, or pale yellow-green solids that are formed during the incomplete
burning of coal, oil and gas, garbage, or other organic substances like tobacco or
charbroiled meat. Structure of representative PAH compounds are showed in Figure 1.
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Figure 1. Structure of PAH compounds (EPA 2008).

The United States Environmental Protection Agency (EPA) has designated 16
PAH compounds as priority pollutants. They are naphthalene, acenaphthylene,
acenaphthene, fluorene, phenanthrene, anthracene, fluoranthene, pyrene,
benzo [a] anthracene, chrysene, benzo [b] fluoranthene, benzo [&]flouranthene,
benzo[a]pyrene, dibenz(ah)anthracene, benzo[g/zz']perylene, and indeno(l,2,3-cd)pyrene
(Lunch 2005). The 16 EPA priority PAHs are often targeted for measurement in
environmental samples. Although the health effects of individual PAHs are not exactly
alike, the Agency for Toxic Substances and Disease Registry (ATSDR) has issued a PAH
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profile as a group for their carcinogenic mutagenic and teratogenic properties. (ATSDR
1995). The Occupational Safety and Health Administration (OSHA) have set a limit of
0.2 milligrams of PAHs per cubic meter of air with the consideration to protect workers'
health. The OSHA Permissible Exposure Limit for mineral oil mist that contains PAHs
is 5 mg/m averaged over an 8-hour exposure period (Rothberg et al.). The National
Institute for Occupational Safety and Health (NIOSH) recommends that the average
workplace air levels for coal tar products not exceed 0.1 mg/m for a 10-hour workday,
within a 40-hour workweek (ATSDR 1995).

Oxidative Stress
Oxidative stress is a general term that characterizes the imbalance by an increase
in pro-oxidant species and/or a decrease in anti-oxidant defense that occur during
oxidative metabolism in biologic systems. Oxidative stress has been suggested as a
major mechanism in biological effects induced by PM (Cruts et al. 2008; Li et al. 2008).
Human studies have associated increased systemic oxidative stress with exposure to
PM2.5 with elevation in plasma levels of thiobarbituric acid reactive substances (TBARS)
of 28 nonsmoking seniors (Liu et al. 2009). This result is in agreement with earlier
reports of increased serum TBARS in association with PM2.5 (Sorensen et al. 2003).
Experimental animal work brings support to the causality notion. Gong has reported that
exposure to the PM2.5 and UFP led to increased hepatic lipid peroxidation, accompanied
by a higher up regulation of Nrf2-regulated antioxidant genes in the mouse livers (Gong
et al. 2007).
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PAHs have been speculated as one of the components of PM inducing oxidative
stress. In humans, the PAHs biotransformation process begins with a cytochrome P450mediated epoxidation of the chemical to become electrophilic intermediates (Georgellis
et al. 1990). These reactive intermediates are then capable of engaging in redox cycling
and produce reactive oxygen species (ROS).
ROS are cellular oxidants which include free radicals such as superoxide (O2O?
hydroxyl (OH-) and peroxyl (ROO-), as well as non-radical species such as hydrogen
peroxide (H2O2). These oxidizing species are common by-products of several cellular
processes including aerobic metabolism, fatty acid oxidation, cytochrome P450 activity,
and the respiratory burst of immune cells (Wiseman and Halliwell 1996). Radiation
exposure can also lead to the formation of cellular ROS (Limoli et al. 2001).
Cells can posses a number of antioxidant defense mechanisms to protect against
the constant generation of ROS, including non-enzymatic scavengers such as glutathione,
uric acid, ascorbic acid and a-tocopherol, as well as the enzymes superoxide dismutase
(SOD), catalase (CAT), and glutathione peroxidase (GPx). In addition, proteins such as
transferrin, metallothionein and ceruloplasmin may act indirectly as antioxidants by
sequestering transition metals responsible for the generation of hydroxyl radicals
(Salganik 2001). The fact that all ROS would be completely removed by these
antioxidant defenses, indicate that ROS may play an important role in cellular functions
and that antioxidants exist primarily to maintain a steady state of ROS (Sanders 2005). A
study of particulate pollutants showed that UFP, collected in Los Angeles area, were used
to study the generation of ROS which caused oxidative stress in macrophages and
epithelial cells, and in turn induces pulmonary inflammation. This result confirmed that
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UFP induced GSH reduction and resulting in cell toxicity (Li et al. 2003). Therefore, in
the event that ROS greatly exceed the antioxidant capabilities of the cell, either by
increased generation of ROS or decreased capability of antioxidant defenses, a condition
termed oxidative stress results (Davies 2000).
ROS plays a critical role in endothelial activation and potentially cause
endothelial dysfunction. Endothelial cell death or injury may contribute to the initial
endothelial physiological processes, such as angiogenesis, atherosclerosis, and
thrombosis. Previous studies have indicated that the vascular endothelium was sensitive
to ROS that can cause cell damage and death. PMio and PM2.5 from Mexico City were
reported to induce endothelial activation and result in alternation of ROS and apoptosis in
human umbilical vein endothelial cells (Montiel-Davalos et al. 2010).
Lipid Peroxidation
ROS is capable of oxidizing damaging macromolecules, including DNA proteins
and lipids (Burcham 1999). A study conducted from the coke oven workers showed that
chronic exposure to PAHs may induced oxidative stress and lipid peroxidation in blood
serum (Jeng et al. 2010). This association between PAHs exposure and oxidative stress
was supported by the measurement of molodeadhyde that was accessed as the parameter
of lipid peroxidation among 120 school children (Bae et al. 2010).
Lipid peroxidation causes bioactive lipid peroxides formation, which can further
oxidize other macromolecules including other fatty acids within membranes (Meerson et
al. 1982). Oxidized phospholipids can also initiate and modulate many cellular events
that attribute to atherosclerosis, which suggests oxidized phospholipids would serve a
biomarker for cardiovascular diseases (Ashraf et al. 2009). Polyunsaturated fatty acids
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play a role of frequent targets of ROS and their susceptibility to oxidation increases with
their degree of unsaturation (Mates and Sanchez-Jimenez 2000). Long chain PUFAs with
more than five double bonds are at greater risk of oxidation than PUFAs with fewer double
bonds, such as linoleic acid. Therefore, lipid peroxidation increases particular concerns
within cellular membranes when peroxide propagation is not terminated by antioxidants,
which can result in large-scale damage to the membrane. Recent studies demonstrated that
lipid peroxidation play an important role in the activation of endothelial cells. For example,
Ashraf detected two specific phospholipids, l-palmitoyl-2-(5-oxovaleroyl)-sn-glycero3-phosphatidylcholine (POVPC), and l-palmitoyl-2-glutaroylsn-glycero-3phosphatidylcholine (PGPC) that were involved with the activation of endothelial cells
cells (Ashraf et al. 2009). Also, a study assessing oxidized low-density lipoprotein
(oxLDL) indicated that lipid peroxidation decrease NO bioavailability which mediate
dilation of isolated coronary arterioles (Hein et al. 2000). Subsequent studies confirmed
the effect via inhibition of the activity of eNOS. (Uittenbogaard et al. 2000; Shaul 2003).
Phospholipid changes induced by lipid peroxidation yield a large number of
oxidation products with different structures, which difficult their isolation and
characterization (Domingues et al. 2008). Mass spectrometry using the ionization
methods is becoming increasingly important in the study of oxidized lipids. Particularly,
ultrahigh resolution techniques such as electrospray ionization (ESI) coupled to Fourier
Transform Ion Cyclotron Resonance Mass Spectrometer (FT-ICR-MS) have significantly
advanced the knowledge of lipid identification and lipid profiling.

Endothelial Dysfunction
The primary mode of entry into the body is through the respiratory system;
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however, the greatest public risk from the air pollution is due to cardiovascular disease
based on the epidemiological data (EPA 2004). An increased incidence of adverse
cardiovascular events has been reported in subjects with impaired endothelial function
compared with subjects with vascular changes, such as decreased vasodilatation,
development of prothrombotic and proinflammatory states and smooth muscle cell
proliferation, all of which contribute to the formation of progression of chronic
atherosclerotic lesions (Bonetti et al. 2003; Libby et al. 2002; Widlansky et al. 2003).
Aging, hypertension, atherosclerosis are important risk factors of stroke and
cardiovascular diseases and seem to be associated with endothelial dysfunction
(Schneider et al. 2008).
The vascular endothelium is important for maintaining vascular homeostasis,
which provides a barrier between the circulation and the surrounding tissues and
contributes in several ways to the local regulation of vascular tone by producing relaxing
and contracting factors. It is known that PM result in increase of ROS in endothelium
(Montiel-Davalos et al. 2010; Delfino et al. 2005). It is also known that ROS reduce
nitric oxide (NO) bioavailability and cause endothelial dysfunction that result in many
non-PM induced cardiovascular diseases (Ohtani and Egashira 2004; Bitar et al. 2005).
In general, PMio can enter the upper large branches of the lung, while smaller particles,
such as PM2.5 can enter the bronchial tubes and penetrate deep to the alveolar portion of
the lung. The solvable PM2.5, such as PAHs, as well as UFPs may reach the
cardiovascular vessel through blood circulation, in which highly reactive ions or
molecules known as ROS are produced. Because of the presence of unpaired valence
shell electrons, ROS are easily attack biological targets that include protein, lipids, and
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DNA. Figure 2 shows that PM-derived ROS may play a critical role in endothelial
activation and potentially cause endothelial dysfunction.
NO, an endothelial-derived relaxing factor (EDRF) is believed to be associated
with endothelial dysfunction. Lack of NO can increase blood pressure and decrease
coronary flow. On the other hand, excess of NO can cause irregular heartbeat. NO is
synthesized endogenously from L-Arginine by various NO synthase (NOS) and released
to smooth muscle cells to regulate vascular relaxation (Figure 3). In the heart, endothelial
NOS (eNOs) is the major form of NOS (Stewart et al. 2009) and is expressed in cardiac
myotytes (Samii 2003), suggesting that eNOS is of importance to regulate NO synthesis
in the cardiovascular system.

Proinflammatory factors:
\ T N F - * , IL-1B, IL-8, etc.

Alveolar Space

Erythrocyte
Monocyte

Figure 2. Systemic effects after PM exposure.
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Though the mechanisms as how PM cause CVDs are not fully known, several studies
have demonstrated that PM can independently cause CVDs in both in vivo and in vitro models
(Polichetti et al. 2009). Figure 4 illustrates possible mechanisms related to PM induced CVDs :
1.

The exposure of PM to the epithelial cells initiates oxidative stress and

inflammation by the generation of ROS. The derivatives of the inflammatory
cells may enter the cardiovascular system through blood circulation. The damage
of the tissue may sicken the patients with previous cardiovascular diseases.
2.

PM2.5 and ultrafine particles can directly pass to the cardiovascular vessel

and contact or penetrate the endothelial cells. These PM can generate ROS, lipid
oxidation and alter the NO bioavailability. Such endothelium dysfunction causes
hypertension and other cardiovascular diseases.
3.

PM may directly impact the autonomous nervous system and as a result,

cause cardiovascular diseases.

y

VASCULAR SMOOTH

MUSCLE CELLS

GC

^**~~
GTP

~ ^ ^
cGMP (a second message)

I

Vascular tone regulation

Figure 3. Nitric oxide biosynthesis.

The second mechanism listed above on the PM-induced endothelial dysfunction
was the focus of this study. The related topics are marked by the shaded boxes in Figure
4. In the cardiovascular disease risk group, studies have shown that the endothelial
dysfunction is usually caused by the increase of ROS, which can generate lipid
peroxidation, oxidize NO and uncouple eNOS (Desjardins and Balligand 2006).
Schneider demonstrated that endothelial dysfunction, including flow-medicated dilation
(FMD) and small artery elasticity is associated with the depletion of NO bioavailability
as well (Schneider et al. 2008). Furthermore, the generated lipid peroxidation can
directly interact with NO (Rudolph and Freeman 2009; O'Donnell and Freeman 2001) or
impair the eNOS activity to further alter NO production (Samii 2003; Rajagopalan et al.
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2005). Rajagopalan hypothesized that PM may follow the same pathways as those
demonstrated in the cardiovascular disease risk group to potentiate the cardiovascular
disease (Rajagopalan et al. 2005). However, very limited studies have been conducted to
confirm the hypothesis that ambient PM and its components do affect NO bioavailability.
Thus, the hypothesis motivates this study to place its focus on the pathways of PM
derived NO bioavailability.

Inhaled PM
from
Ambient AII

Pulmonary
Deposition

Pulmonary
Oxidative Stress
mediated by ROS

Translocation in
Blood

Vascular
Oxidative Stress
mediated by ROS

Endothelial cell
Activation

Intercellular
ROS

Release and
increase cytokines
in Blood. IUML-*.

effect

MO Biosynthesis.
eNOS activity

Homeostasis and
Clot Formation

Platelet aggregation:
Vascular Tone
Regulation

Systemic

Oxidized Lipids

Decrease
Coronary Flow

Endothelial
Dysfunction

Increase Blood
Pressure

V M 7

J ^

Cardiovascular Disease:
Hypertension:
Atherosclerosis; Coronary
Artery Disease:

SM0KMG < j ^

•^ STRESS

<"

Heart foDure;
Metabotc Syndrome

Figure 4. Hypothetical pathways of PM into cardiovascular system. (Delfino et al. 2005;
Simkhovich et al. 2008) * represents the related reference in the hypothesis.
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SPECIFIC AIMS
The central hypothesis of this study is that through ROS and lipid peroxidation,
PAHs affected NOS, which in turn altered the biosynthesis process of NO (Figure 5).
The investigated pathways were summarized as follows. PAHs activated endothelial
cells, therefore increased intracellular ROS generation, which in turn oxidized lipids in
the cell membranes and inhibitted eNOS activity.

Endothelial (In Vitro)
cells line

Figure 5. Possible PM-mediated Pathways on lipid peroxidation and NO bioavailability
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To address the proposed hypothesis, specific aims were to:
•

Confirm that PM exposure increased the generation of ROS, which
resulted in oxidative stress in endothelial cells.

•

Access whether PAHs increase oxidative stress in endothelial cells.

•

Determine alteration of lipid profiling induced by lipid peroxidation.

•

Assess whether PM and/or PAHs affect NO bioavailability by
determining NO concentration and eNOS activity

•

Determine whether PM and/or PAHs inhibit eNOS catalytic activity in
relation to lipid peroxidation.

SIGNIFICANCE
The findings from this study increased the understanding of how PAHs alter
endothelial cell function and damage via the pathway mechanism by which cells undergo
oxidative stress. The results of this study would provide new insights into the
mechanisms related to PM induced cardiovascular diseases, particularly atherosclerosis.
On health perspectives, the finding of this study would link air pollution to cardiovascular
diseases in biochemical terms, which pave a way to further investigate the adverse effects
of PM exposure. Such knowledge will increase awareness of health risks of ambient
particles and as a result, make us more sensitive to the control of the emissions and
compositions of PM.
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CHAPTER II
POLYCYCLIC AROMATIC HYDROCARBONS AS THE MAJOR
COMPOENTN OF PARTICULATE MATTERS INDUCE OXIDATIVE EFFECTS
TO ENDOTHELIAL CELLS IN VITRO

INTRODUCTION
Organic extracts of PM can produce superoxide and hydroxyl radical during
incubation at 37 °C with or without biological activation system (Wells et al. 1997).
PAHs in PM are the most abundant non-polar substances in the urban atmosphere and
have become pollutants of serious concern. After absorption, PAHs are efficiently
metabolized in many human tissues, especially in the vascular vessels. Alveolar capillary
endothelium lies close to alveolar epithelium (Bai et al. 2001), thus the inhaled PAHs in
PM may easily interact with vascular endothelium and blood by producing reactive
oxygen and soluble materials.
Currently, there is no available data regarding PAHs toxicity on human coronary
artery endothelial cells (HCAEC) in order to assess its role on PM-induced
cardiovascular diseases. This study aimed to evaluate the oxidative stress generated in
HCAEC induced by PAHs exposure. Specific aims include: 1) investigate cytotoxicity
induced by PM to confirm its effects observed in the literature; 2) examine cytotoxicity
and ROS generation in human endothelial cells induced by PM and PAH exposure.
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EXPERIMENTAL PROCEDURES
Materials
A23187 calcium ionophore was obtained from Sigma-Aldrich (St.Louis, MO). Albumin
standard was obtained from Pierce (Rockland, IL). Apocynin was obtained from Fisher
Scientific (Pittsburgh, PA). P-Nicotinamide adenine dinucleotide phosphate, reduced tetra
(cyclohexylammonium) salt was obtained from Sigma-Aldrich (St.Louis, MO). 99.8%
chloroform was obtained from Acros (Thermo). Cell culture flasks and dishes were
obtained from Corning (Corning, NY). Cell lysis buffer was obtained from New England
Biolabs (Beverly, MA) and supplied as 1 OX cell lysis buffer. 8 chamber tissue culture
treated glass slide was obtained from BD Falcon (Bedford, MA). Comassie protein assay
kit was obtained from Pierce (Thermo, Rockford, IL). Disel particulate matter was
obtained from National Institute of Standards and Technology (NIST, Geithersburg, MD).
Dimethyl sulfoxide (DMSO) was obtained from Sigma. Ethylenediaminetetraacetic acid
(EDTA) was obtained from Sigma. Ethylene glycol-bis(2-aminoethylether)-N,N,N',N'tetraacetic acid (EGTA) was obtained from Sigma. Glass tubes, borosilicate (16x100mm),
were obtained from Fisher. Human coronary artery endothelial cells (HCAEC) were
purchased from Cell Applications, Inc. (San Diego, CA) and grown in culture at 37°C
and 5% C02 cells were grown in Medoendo Eell Growth Media. Hank's balanced salt
solution, calcium- and magnesium-free (HBSS) was obtained from Mediatech Cellgro
(VA).30% H2O2 was obtained from Fisher Scientific. Homogenizer was obtained from
Fisher Scientific. H2DFFDA was obtained from Invitrogen. Isopore membrane filters,
3.0um TSTP and 1.2 um RTTP, were obtained from Millipore (Billerica, MA). 8Isoprostane Express EI A Kit (Catalog #516360) was obtained from Cayman Chemical
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(Ann Arbor, MI). Lactate dehydrogenase (LDH) Kit (Cat.# 04744926001) was obtained
from Roche. P-Nicotinamide adenine dinucleotide phosphate, reduced
tetra(cyclohexylammonium) salt (NADPH) was obtained from Sigma. 99% methyl
alcohol was obtained from Acros (Thermo). Mounting medium for fluorescence with
DAPI was obtained from Vector (Burlingame, CA). Noo-Nitro-L-arginine methyl ester
hydrochloride (L-NAME) was obtained from Sigma-Aldrich (St.Louis, MO).
Polypropylene centrifuge tubes (15ml) were obtained from Corning Inc. (Corning, NY).
Polycyclic aromatic hydrocarbons were obtained from Restek (Bellefonte, PA). Sodium
dodecylsulfate (SDS) was obtained from American Bioanalytical. Sodium hydroxide
(NaOH), ION solution, 30% w/w, was obtained by Fisher Scientific. Thiobarbituric Acid
Reactive Substances (TBARS) Assay Kit (CatJ 0801192) was obtained from
ZeptoMetrix Corporation (Buffalo, NY). Total Nitric Oxide Assay Kit (Lot # KGl34678)
was obtained from Thermo Scientific (Rockford, IL). Triton-XlOO was obtained from
Fisher Scientific. Trypan blue solution (0.4%) was obtained from Sigma-Aldrich
(St.Louis, MO). Phosphate buffered saline 10X was obtained from Fisher Scientific.
PTFE cap and target vials were obtained from Fisher scientific. All aqueous solutions
and reagents were prepared in deionized distilled water using ELGA Purelab system from
SIEMENS.

Cell Culture and Preparation
Endothelial cells are economical alternative, suitable for studies of endothelial
functional and endothelial metabolism. Changes in structure and function of these cells
have been linked to vascular diseases such as atherosclerosis, and hypertension. Human
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coronary artery endothelial cells (HCAEC) used in this study was isolated from normal
human coronary arteries from Cell Application (San Diego, CA). HCAEC were grown in
Mesoendo Cell Growth Medium that is fully supplemented with fetal bovine serum,
growth factors, trace elements and antibiotics. The cells in culture flasks were placed in
an incubator at 37 °C with a humidified atmosphere of 5 % CO2. Cells were preserved
and stored with liquid nitrogen in a cryosystem (Cryogenic locator, Thermo).
HCAEC was cultured for treatment when cells are about 80-90% confluent. Cells
were used for all experiments on the passages 5 to 15. Active proliferation cells were
exposed to fine particle or PAHs solutions prepared as described below. After exposure,
cells were harvested from cultured flask. This involves removal of media from flask, a
rinse with Hank's Balanced Salt Solution IX, trysin EDTA IX 0.25 % trypsin/2.21 mM
EDTA in HBSS addition and Mesoendo Cell Growth Medium addition. HCAEC
preparation prior to bioassays involves centrifugation at 1092 rpm (200g), removal
supernatant, followed by HBSS wash twice. Cell count was performed using a
hemacytometer.

Particulate Matter Preparation
Diesel particulate matter (DPM), 2975-Industrial forklift, was obtained from
National Institute of Standards and Technology (NIST, Geithersburg, MD). The
certificate of analysis of DPM provided concentrations of PAH (i.e. phenanthrene,
fluoranthene), the percent of extractable mass, and particle size (Appendix A, Appendix
B, Appendix C).
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Since the average particulate size of the DPM was less than the inhalation average
particulate size established by the American Conference of Government Industrial
Hygienists (ACGIH), proper inhalation/respiratory protection was employed according
to the Occupational Safety and Health Administration (OSHA) Respiratory Protection
Standards 29 CFR Part 1910.134 (Protection. Regulations (Standards-29 CFR)).
Fine particle were isolated from diesel particulate matter using a multistep
filtration process to remove particles and agglomerates larger than 3 um. Briefly, diesel
particulate matter was weighted and suspended in HBSS to reach a concentration of 15
mg/L. The particulate matter was vigorously stirred; the suspension was sonicated in a
water bath sonication for 15 minutes. The homogenous suspension was filtered through a
3-um pore polycarbonate filter. This process moved particles and agglomerates > 3 um
in diameter. The filtrate was filtered through 1.2 um pore polycarbonate filter once again,
which removed particles with diameters > 1.2 um. The final filtrate containing fine
particle was used to treat cells. The particle solution was prepared and diluted
immediately before cell exposure, and diluted as required.

Assessment of Particle Size Distribution
Size distribution of particles was measured by Zetasizer (Nano-series, Malvern
Instruments). The zetasizer performs size measurements by first measuring the Brownian
motion of the particles in a sample using Dynamic Light Scattering (DLS), Bronian
motion is defined as the random movement of particles in a liquid due to the
bombardment by the molecules that surround them. And then relate this to the size of the
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particle by illuminating the particles with a laser and analyzing the intensity fluctuations
in the scattered light.
Fine particle were prepared and diluted as described above. Size distribution was
displayed by intensity graph as a higtogram, with logarithmic X-axis and linear Y-axis
settings.

Polycyclic Aromatic Hydrocarbons Preparation
EPA method 8310 PAH Mixture was obtained from Restek Corporation.
Acetonitrile with composition of 99.1 % was used as solvent. Certificate of analysis
provided PAH compound and concentration (Appendix D). Ultrasonication was used to
remove air bubbles or to breakup agglomerates before loading 1 ml of the sample into
disposable polystyrene cuvettes. The PAH solution was prepared and diluted
immediately before cell exposure, and diluted as required. Cells were exposed to PAH
with variable factors of exposure, including the concentration and the duration time of
exposure.
Personal protection was taken followed the safety data sheet to prevent exposure.
Respiratory mask, safety glasses, and gloves were used to protect respiration, eyes and
skin when handling PAHs (RESTEK 2010).

Assessment of Polycyclic Aromatic Hydrocarbons Cytotoxicity
Lactate dehydrogenase (LDH), a stable enzyme located in the cytosal, was rapidly
released into the surrounding culture medium upon cell membrane damage or lysis,
processes that occur during both apoptosis and necrosis. The LDH activity was
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determined in an enzymatic test, firstly LDH catalyzes the reduction of NAD + to
NADH/H+ by oxidation of lactate to pyruvate. In the second step, diaphorase transfers the
new-formed NADH and H+ to catalyze the reduction of a tetrazolium salt (INT) to
highly-colored formazan which absorbs strongly at 492 nm.
The Cytotoxicity Detection Kit (Roche Applied Sciences, Germany) was used for
quantitating cytotoxicity of PAH to cells. Based on the preliminary study on
determination of the optimal cell concentration, a density of 2.5 x 10 cells/well was
decided to seed in a 96-well plate with 100 ul of culture medium per well. The procedure
was followed according to the manufacturer's instructions. The cytotoxicity was
calculated and described as percentage.

Evaluation of Cell Morphology
Cell morphology was viewed by Nikon Light microscopy TS 100. The bright
field images were captured by a Cool Snap EZ camera.
The flow cytometry was also employed to analyze many properties of many cells
and to study cell morphology with a number of detectors, which were aimed at the point
where the stream passes through the light beam, one in line with the light beam (Forward
Scatter or FSC) and several perpendicular to it (Side Scatter or SSC) and one or more
fluorescent detectors. The intensity of FSC signal has been attributed to cell size,
refractive index or membrane permeability. The intensity of SSC signal was proportional
to the amount of cytosolic structure in the cell, such as granules and cell inclusions,
where laser light that was scattered at 90 degrees to the axis of the laser path is detected
in the side scatter channel. Since FSC associated with the cell size and SSC depended on
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the inner complexity of the particle, a correlated measurement between them can allow
for differentiation of cell types in a heterogenous cell population.

Evaluation of Cell Viability
HCAEC were cultured as previously mentioned, and were harvested from the
cultured flask, washed, and then resuspended. Cell viability was assessed by staining
with 0.02 % trypan blue in HBSS, and cell counts of 100 cells were performed using a
hemacytometer after 2 minutes with a Nikon Eclipse TS 100 light microscope.

Detection of Reactive Oxygen Species
ROS detection was performed using the Image-iT LIVE Green Oxygen Species
Detection Kit (Molecular Probes). The assay is based on 5-(and-6)-carboxy-2', 7'dichlorodihydrofluorescein diacetate (carboxy-HaDCFDA), a cell permeable, non-polar,
H202-sensitive fluorogenic probe for ROS in live cells. Oxidation of this probe can be
detected by monitoring the increase in fluorescence with a fluorescence microscope,
using excitation sources and filters appropriate for fluorescien (FITC) (Oksvold et al.
2002; Konorev et al. 2000).
The procedures of labeling with Carboxy-H2DCFDA are as follows:
Prepare a 10 mM carboxy-H2DCFDA stock solution by adding 50 uL of DMSO
to one vial of carboxy-H2DCFDA to make a 10 mM stock solution. Vortex the vial until
the powder is completely dissolved. Then prepare 25 uM carboxy-H2DCFDA working
solution by adding 5.0 uL of the 10 mM carboxy-H2DCFDA stock solution to 2.0 ml of
warm HBSS buffer. After that, cells are washed gently with warm HBSS followed by
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labeling cells. In order to do so, apply a sufficient amount of the 25 uM carboxyH2DCFDA working solution to cover the cells adhering to the cover-slip. Incubate for 30
minutes at 37 °C, protected from light. Again, cells are washed gently twice in warm
HBSS. The final step is to mount cells in warm buffer and image immediately by
mounting medium, using a DAPI filter set and neutral density filter(s) to assist with
locating the cells on the cover-slip, followed by a fluorescein filter set for imaging.

Quantification of ROS
2', 7'- difluorodihydrofluorescein (CI3293, Invitrogen), an oxidant by-product of
5-(and-6)-carboxy-2', 7'- difluorodihydrofluorescein diacetate (carboxy-H2DFFDA), was
used to assess the ROS generation in HCAEC. Cells were incubated with H2DFFDA (10"
5

M) for 0.5 hour at 37 ° C and washed twice with Hank's Buffered Salt Solution.

HCAEC were after cultured in the presence or absence of fine particles or PAHs for 1
hour. H2O2 (100 uM) was used as a positive control to induce oxidative stress. After an
extensive wash, fluorescence of fine particle treated cells was evaluated by flow
cytometry (FASCCalibur, Becton Dickinson) at Eastern Virginia Medical School
(Norfolk, VA); fluorescence of PAHs treated cells was evaluated by flow cytometry
(FASCAria, Becton Dickinson) at Bioelectric Center, Old Dominion University (Norfolk,
VA). The mean fluoresce intensity was calculated by multiplying the number of
fluorescent cells by the mean of the intensity presented by the Flow-Jo software used for
the analysis.
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Statistical Analysis
Statistical analysis was performed using Sigma-Plot software. All experiments
were carried out in triplicate, and results were expressed as means ± standard error of the
mean (SEM). Comparisons involving three or more groups were evaluated using oneway ANOVA and an appropriate post hoc comparison. Instances involving only two
comparisons were evaluated with a Student's Mest. Differences among means were
considered statistically significant by the criterion of probability P value < 0.05.
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RESULTS
Size distribution of PM
In the initial phase of investigation, the size distribution of the fine particles after
filtration has been analyzed by the Zetasizer Nano series from Malvern. Size distribution
of fine particles is showed in Figure 6. After filtration with 3.0 um pore size filter,
particles with larger size in DPM were removed. In the filtrate, 82.6% of particles had
diameters at 220.8 nm on average, 17.4% of particles had diameters at 4827 nm. After
filtration with 1.2 um pore size filter, 94% of particles were at the diameter of 262.3 nm,
and 6% of particles were at 4546 nm. From the correlation graph, we conclued that this
results met the quality criteria. The prepared fine particles at this step were used in the
following studies.
The filtrated fine particles were smaller in mass than DPM; they also had larger
surface area to contact with cells. In addition, their numbers are higher as compared to
other particles. Thus, fine particles had the potential to enter blood stream and affect the
endothelium directly.
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Figure 6. PM size distribution by Zetasizer Nano Series. PM size correlation data (A),
size distribution by intensity (E). Green line and red line represent particle size
distribution after filtration with 3.0 um pore size filter and with 1.2 um pore size filter,
respectively.
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Cytotoxicity of PM
Cell morphology changed after PM exposure
Figure 7 showed control cells, cells treated with PM, PM only groups. Cell size
was measured and showed in Table 1. After PM treatment, size of HCAEC decreased
32.5 % compared to control, illustrating that cell shrinkage took place after PM exposure.
Results were presented as mean ± SEM of 10 independent experiments and were
expressed as um,/? < 0.05 are considered as significant differences.
Cells were washed twice with HBSS after exposure, and then images were taken
under bright field microscopy. HCAEC morphology had obviously changes after PM
treatment (Figure 7). Cell shape turned to be elliptical. Particles were observed to pass
through the cells membrane and enter the cells indicated as the arrows in Figure 7B.
Decreases in cell size were also noticed after PM exposure. It is likely that PM
comprised integrity of cell membrane that allows cytosol and intracellular fluid leaked to
the surroundings.

Table 1. HACEC size measurements. Sample number counted in each group is 10;
* indicates PO.0001 compared with cells only

Cells sizes, um

Cells Only

PM treated Cells

PM only

30.8 ±1.48

20.8 ± 1.04 *

3.0

fa:
i

y
A

B

Figure 7. Cell morphology changed after PM treatment (400X). Cells Only (A), 1 mg
PM for 1.0 hour treatment (B), PM only ( Q . Cell images were token with a Nikon
diaphot light microscopy.
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Cell viability changed after PM exposure
After PM exposure, cell populations had an obvious shift from the histograms in
Figure 8 from the flow cytometer results, the whole group had the trend to move to the
upper left. Also cell shrinkage took place due to the stimulation of PM.
FSC readings decreased, indicating that cell size was reduced. The increased
reading of SSC showed that the internal structure of HCAEC altered and the granularity
on cell membrane increased. Cell viability decreased since more debris had been noticed
after PM exposure as well as the H2O2 treatments as a positive control. These
observations confirmed the results that cell shrinkage took place after PM exposure, the
shape of nucleus were changed, cell membrane was damaged and resulted in membrane
roughness due to the increasing amount of cytoplasm granules.
After PM exposure, cell viability decreased in both 0.5 hour and 1.0 hour
incubation groups. More dead cells were dyed with trypan blue in PM treated groups,
revealing that cell membrane was injured. HCAEC viability of 0.5 and 1.0 hour PM
exposure decreased 1% and 5%, respectively, compared to control in Figure 9. HCAEC
treated with H2O2 decreased 18.7%. We expected to see harsh effects to cell viability
after PM exposure; however, the reading has no significant decrease, nor time- dependent
pattern.
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Figure 8. Histograms of PM treated cells. HCAEC were treated with 1 mg/L PM for 0.5
and 1.0 hour, following with H2DFFDA dye. 100 uM/ml H2O2 were introduced to cells
as positive control. Cell population was displayed and distributed with a flow cytometer.
Cells gated in rectangle with percentage were counted as total cells. Cells gated in
elliptical with percentage of total cells were counted for viability analysis.
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Figure 9. Cell viability after PM exposure. HCAEC were incubated with 1 mg/L PM for
0.5 and 1.0 hour. 100 uM/ml H2O2 were introduced to cells for 0.5 hour as positive
control.

ROS generation by PM treated HCAEC
Fluorescent dye DCFDA was detected in the cells exposed to PM at
concentrations of 0.1, 1 and 10 mg/ml. The fluorescent intensity from those treated cells
by PM was significantly increased as compared to the control (Figure 10). Interesting,
the cells treated by PM at 1 mg/ml seemly had strong fluorescent expression than those
treated by 10 mg/ml PM. The higher concentration of PM at the concentration of 10
mg/ml may overshadow the fluorescence intensity. The flow cytometry method
confirmed that fluorescence from the dye DFFDA was generated in the cells treated by
PM (Figure 11). PM induced ROS generation in HCAEC after 1.0 hour exposure, while
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PM has mimmal effects on ROS generation in HCAEC after 0.5 hour exposure (Table 2).
No significant differences existed between PM treated groups and the control (p value of
PM 0.5 hour treatment is 0.210, p value of PM 1.0 hour treatment is 0.031). The
inconsistent results may be caused by the attachment of the fine particles on cell
membrane and/or translocation of fine particles into the cells blocked fluorescence, and
subsequently altered the degrees of fluorescent intensity detected by a flow cytometer.

Control

1 mg/ml

100 ug/ml

10 mg/ml

Figure 10. Effects of PM on ROS generation. HCAEC was exposed to 0.1, 1 and 10
mg/ml PM concentrations for 12 hours following with the incubation with CarboxyH2DCFDA. (400x)
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Table 2. Fluorescence of PM treated groups
Treatment
Fluorescence
Units Mean

Control
660

PM, 0.5 hour
639

PM, 1.0 hour
723

H202
845

Cytotoxicity of PAHs exposure
Cell morphology and variability change after PAHs exposure
Figure 13 shows cell treated with PAHs were shrunk and detected from the
culture flask. After exposure to PAHs for 0.5 h, cell morphology was noticeably changed,
granularity increased, shrinkage was observed, and viability decreased. A group of
particles were noticeably appeared at the left of the cells in the PAHs treated groups,
which were PAHs after comparing with the histogram result of the cell-free PAHs.
PAHs decreased viability of endothelial cells in a concentration-dependent
manner. Since 3 hour exposure of PAHs decreased cell viability significantly at the
concentration higher than 10 ug/ml, and has more harsh effects than 1 hour. Thus, the
concentration of PAHs with no more than 15 ug/ml, has been chosen in the following
studies.
PAHs concentrations at < 7.5 ug/ml did not alter viability of endothelial cells
after incubation for one and three hours. At the concentration of lOug/ml, PAHs started
causing decreased cellular viability in three-hour contact. The degree of the cytotoxicity
continues to increase as the increase in PAH concentrations. After three hours exposure,
significant differences were observed from PAHs 10, 15 and 25 ug/ml groups in
comparison with control, p values were 0.0006, 0.0002 and 5.306E-20, respectively.
That demonstrates the effect was in a dose-depended fashion
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LDH is a stable enzyme located in the cytosal, which rapidly release into the
surrounding culture medium upon cell membrane damage or lysis, this processes occur
during both apoptosis and necrosis. This method indicated that integrity of cellular
membrane was comprised by PAHs exposure to allow cytosol to release from the inside
cells to the surrounding culture medium At the same time, the LDH assay showed that
PAHs caused cytotoxicity to HCAEC.

t.

Control

H 2 0 2 exposure

i

\
i

x

1 ug/ml of PAHs

5 ug/ml of PAHs

12 ug/ml of PAHs

Figure 12. Cell morphology after PAHs exposure. Cells were treated with 0 (control), 1,
5 and 12 ug/ml of PAHs for 0.5 hour, respectively. Cells treated with H2O2 were used as
positive control. Cell images were token under lOOx
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Figure 14. Cytoxicity of PAHs to HCAEC. HCAEC were incubated with different
concentrations of PAHs, 0 (control), 0.5, 1.25, 2.5, 7.5, 10, 15, 25, and 50 ug/ml and
cultured in HBSS at 37 °C for land 3hours. Lactate dehydrogenase method was used to
measure the cytotoxicity of PAHs. LDH released into the media was assessed. Results are
presented as mean ± SEM of three independent experiments and are expressed as
percentage,/? < 0.05 are considered as significant differences.
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Vehicle effects on HCAEC
Cell morphology changed after CH3CN exposure
99%o pure acetonitrile were used as solvent in PAHs stock. After a series of
dilution, the concentration of acetonitrile in the PAHs suspension for exposure was no
more than 2%. Acetonitrile is colorless liquid that is mainly used as a polar aprotic
solvent in purification of butadiene. Acetonitrile has only a modest toxicity in small
doses (Wexler 2005). To ensure the observed cytotoxicity induced by PAHs instead
solvent used to disovle PAHs, 2% CH3CN was examined any toxic effects on HCAEC.
Cell morphology has no significant differences after acetonitrile treatment (Figure 15).
Cell distribution in vehicle treated group was the same with control from the histograms
results in Figure 16.
ROS generation after CH3CN exposure
No significant increase of ROS was observed from the results in Figure 17 (p
value = 0.17). Therefore, the increase of ROS level and cell activation in the PAHs
treated groups were not due to the effects of acetonitrile.

ROS generation in HCAEC after PAHs exposure
Microscopy photographs illustrated 1 and 5 ug/ml PAHs t induced the gerenation
of ROS after 0.5 hour contact (Figure 18). Fluorescent cells were found in the PAHs
treated groups, while absent in the control and vehicle treated group.

Control

Vehicle

Figure 15. Cell morphology after vehicle treatment. Cells were treated with 0 (control),
2% CH3CN for 0.5 hour, respectively. Cell images were token under lOOx.
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Figure 17. Vehicle effects on ROS generation. Cells treated with 2% acetonitrile for 0.5
hour as vehicle.

ROS dye

DAPI

Merged

Control

PAH, lug/ml

WkH;5w/ml

Figure 18. Fluorescent images of ROS after PAHs exposure. HCAEC were treated with
0 (control), 1 and 5 ug/ml PAHs for 0.5 hour. The cells were stained with carboxyH2DFFDA, then mounted with DAPI (blue: nucleus), cover slipped and viewed by a
Nikon Eclipse 80 i microscope and cells were captured with a Cool SNAP EZ camera.
(lOOx)
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Figures 20 and 21 showed fluorescence generated in PAHs treated cells. A
representative overlapped results of PAHs treated cells showed that the fluorescence of
total cells shifted to the left (Figure 19). This indicates that the fluorescence reading
increased after PAHs exposure as compare with the control. Also, all of the HCAEC
exposed to 1, 5, and 12 ug/ml PAHs induced significant increases in ROS in HCAEC as
compared to the control (p values all < 0.05). The ROS level in the 1 ug/ml treated group
was more than three times higher than the control. 5 and 12 ug/ml PAHs exposure
induced 468% and 548% increases in ROS concentrations, respectively, as compared to
the control. Therefore, a dose-dependent pattern was observed.
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Figure 19. Oxidative effects of PAHs treatments. Gray, green and red lines represent
cells treated with 0 (control), 1 and 5 p.g/ml of PAHs, respectively. Data are the mean ±
SEM of three independent experiments. * Indicates p < 0.05 in comparison with the
control group.
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Figure 21 shows the effect of exposure duration on ROS generation. No
significant differences were observed between 0.5 and 1 hour exposure at 5 ug/ml and 12
ug/ml PAHs. The results suggested that 0.5 hour PAH exposure could maximize the
ROS generation in the endothelial cells.
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Figure 21. Time effects of PAHs on ROS production. Cells treated with 1, 5 and 12
ug/ml of PAHs for 0.5 and 1 hour, respectively. Data are the mean ± SEM of three
independent experiments. * Indicates/? < 0.05 in comparison with the control group.
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DISCUSSION
Previous research had shown that PM extracts caused damage to vascular
endothelial cells in vivo (Ichinose et al. 1995). Researchers also have found different
results of the association between PM sizes and cytotoxicity (Churg and Brauer 1997).
However, whether PM or PAHs causes direct cell damage in HACEC has not been
clearly described. The study showed that PM induced acute cytotoxicity to endothelial
cells. The findings were similar with other studies. The activation of human umbilical
vein endothelial cells induced by PM2.5 and PMio has been reported to associate with an
oxidative stress (Montiel-Davalos et al. 2010). Van Eeden reported that endothelial
activation by PM may be due to pro-inflammatory factors released in the lung or to a
direct contact of PM with the endothelium (van Eeden et al. 2005).
Fine particles with the size less that 3 um compromised and damaged the cell
membrane integrity to the degree that alters cellular morphology. Also, cell permeability
was altered since cytosol was leaked out from HCACE. The cell injury could be
associated with a decrease in the content of phospholipids (Prasad 1991). Particles were
found to either bind outside cell membrane or enter into the cells. Subsequently, HCAEC
viability was decreased after PM exposure. Although the mechanism of cell death was
not investigated in this study, it is usually undergoing either apoptosis or necrosis. PM
were proved to induce cell apoptosis in RAW 264.7 and J774 cells and human alveolar
macrophages by activating the TNF-a-induced pathway (Huang et al. 2004; AlfaroMoreno et al. 2002). Similar with PM, PAHs were observed to induce acute cytotoxicity,
including the damage to the cell membrane integrity and decreased viability. PAHs were
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likely the major component that contributes to acute cyotoxicity to endothelial cells
induced by PM.
The ROS level is an important characteristic in the cellular responses to external
stress. Moreover, increase in ROS level initiates various responses within the cell,
including damage to proteins, DNA and lipid (Halliwell 2001). In order to measure the
ROS level in HCAEC, two fluorescent probes were used in this study. Fluorescent dye,
carboxy-H2DCFDA, can be taken up by live cells and are able to emit fluorescence upon
oxidation which can then be monitored using digital microscopy. After 12 hours of PM
exposure, cell viability decreased, correlating with the increasing of ROS levels. ROS
detection with a fluorescent microscopy after 24 hours of PM has no significant
difference with the ones after 12 hours incubation. Possible reasons could be that the fine
particles likely aggregate during the exposure or the fluorescence leaked out from the
cells. The effects of PAHs with 1 and 5 ug/ml induced the increase of ROS were
obviously noticed in HCAEC.
In order to quantify the level of ROS, the flow cytometry method was used with
the fluorinated derivative, H2DFFDA, which exhibits improved photo stability compared
to chlorinated fluorescein derivatives. This dye also shows exceptional retention in live
cells due to the reaction of thiols with the fluoromethyl group which "traps" the
difluorodihydrofluorescein in the cell. Oxidation by ROS yields a fluorescent
difluorodihydrofluorescein which is detectible. After the cells treated with PAHs with
the concentrations from 1, 5 and 12 ug/ml for different time periods, ROS intensity were
significantly increased as compared to the control. The study clearly showed that PAHs
induced the generation of ROS in the endothelial cell. PAHs on PM could be undergone
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bio-transformation via cytochrome P450 to yield reactive electrophiles and superoxide
hydroxyl radicals and continue the pathway involved with redox cycling to generates
excessive concentrations of ROSs, such as H 2 0 2 , superoxide and hydroxyl radical
(Shimizu et al. 2003).
The results demonstrated an imbalance of the production and the manifestation of
ROSs, which can lead to oxidative stress to the cells. Excessive of the ROS production
can disturb the redox status that lead to toxic effects to cells including alteration of cell
morphology and the decrease in cellular viability.
In conclusion, PAHs induced acute cytotoxicity to endothelial cells via oxidative
stress. PAHs on PM could increase the risk of the damage to endothelial cells in relation
to cardiovascular disease. Thus, the control of emissions and compositions of PM is the
important to the protection of public health..
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CHAPTER III
POLYCYCLIC AROMATIC HYDROCARBONS CHANGE LIPID PROFILE
AND NITRI OXIDE BIOAVAILABILITY TO ENDOTHELIAL CELLS IN VITRO

INTRODUCTION
Enhanced production or attenuated degradation of ROS leads to oxidative stress
that affects endothelial and vascular function, which in turn contributes to vascular
disease. Several pathological conditions increase the production of ROS in the vascular
wall, such as diabetes and hypertension. These conditions are associated with endothelial
dysfunction and cardiovascular disease. Among the arterial vascular tree, endothelium is
the key member. Nitric oxide, a product of the normal endothelium, principally
determined normal endothelial and vascular function (Montiel-Davalos et al. 2010), and
increased in states of inflammation and contributed to oxidative stress in conjunction with
other ROS (Lubos et al. 2008). Oxidative stress is proved to associate with lipid
peroxidation as well. Lipid peroxidation is a major contributor to the related loss of
membrane integrity, and with respect to pore formation and accumulation of unspecific
lipid-protein adducts from aldehydic end products, such as malondialdehyde (Gujral et al.
2004). Therefore, the biological importance of lipids has drawn extensive attention to the
analysis of lipid diversified molecular species. Latest characterizations by soft ionization
Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) have been
increasingly utilized to profile global lipid distribution (Ivanova et al. 2001; Jones et al.
2005; Saghatelian et al. 2004; Yu 2006). For example, electrospray ionization FT-ICRMS of total lipid extracts has been reported to be useful in detecting differences between
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the distributions of highly heterogeneous mixtures of lipids found in eukaryotic cells
(Ivanova et al. 2001). Thus, 12T FT-ICR-MS was performed in this study to access the
lipid profiling on HCAEC.
Previous research showed that the bioactive lipids, especially oxidized
phospholipids, can initiate and modulate many cellular events that attribute to
atherosclerosis, suggesting that oxidized phospholipids would serve a biomarker for
cardiovascular disease (Ashraf et al. 2009). Thus, this work aimed to evaluate 1) whether
lipid peroxidation is linked to endothelial dysfunction in the HCAEC exposed to PAHs,
and 2) whether the treatment of human endothelial cells with PAHs can alter the lipid
profile and NO generation due to a disruption in redox balance.
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EXPERIMENTAL PROCEDURES
Materials
A23187 calcium ionophore was obtained from Sigma-Aldrich (St.Louis, MO). Albumin
standard was obtained from Pierce (Rockland, IL). Apocynin was obtained from Fisher
Scientific (Pittsburgh, PA). P-Nicotinamide adenine dinucleotide phosphate, reduced tetra
(cyclohexylammonium) salt was obtained from Sigma-Aldrich (St.Louis, MO). 99.8%
chloroform was obtained from Acros (Thermo). Cell culture flasks and dishes were
obtained from Corning (Corning, NY). Cell lysis buffer was obtained from New England
Biolabs (Beverly, MA) and supplied as 10X cell lysis buffer. 8 chamber tissue culture
treated glass slide was obtained from BD Falcon (Bedford, MA). Comassie protein assay
kit was obtained from Pierce (Thermo, Rockford, IL). Disel particulate matter was
obtained from National Institute of Standards and Technology (NIST, Geithersburg, MD).
Dimethyl sulfoxide (DMSO) was obtained from Sigma. Ethylenediaminetetraacetic acid
(EDTA) was obtained from Sigma. Ethylene glycol-bis(2-aminoethylether)-N,N,N',N'tetraacetic acid (EGTA) was obtained from Sigma. Glass tubes, borosilicate (16x100mm),
were obtained from Fisher. Human coronary artery endothelial cells (HCAEC) were
purchased from Cell Applications, Inc. (San Diego, CA) and grown in culture at 37°C
and 5% C02 cells were grown in Medoendo Eell Growth Media. Hank's balanced salt
solution, calcium- and magnesium-free (HBSS) was obtained from Mediatech Cellgro
(VA).30% H2O2 was obtained from Fisher Scientific. Homogenizer was obtained from
Fisher Scientific. H2DFFDA was obtained from Invitrogen. Isopore membrane filters,
3.0um TSTP and 1.2 um RTTP, were obtained from Millipore (Billerica, MA). 8Isoprostane Express EI A Kit (Catalog #516360) was obtained from Cayman Chemical
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(Ann Arbor, MI). Lactate dehydrogenase (LDH) Kit (Cat # 04744926001) was obtained
from Roche. P-Nicotinamide adenine dinucleotide phosphate, reduced
tetra(cyclohexylammonium) salt (NADPH) was obtained from Sigma. 99% methyl
alcohol was obtained from Acros (Thermo). Mounting medium for fluorescence with
DAPI was obtained from Vector (Burlingame, CA). Nco-Nitro-L-arginine methyl ester
hydrochloride (L-NAME) was obtained from Sigma-Aldrich (St.Louis, MO).
Polypropylene centrifuge tubes (15ml) were obtained from Corning Inc. (Corning, NY).
Polycyclic aromatic hydrocarbons were obtained from Restek (Bellefonte, PA). Sodium
dodecylsulfate (SDS) was obtained from American Bioanalytical. Sodium hydroxide
(NaOH), ION solution, 30%> w/w, was obtained by Fisher Scientific. Thiobarbituric Acid
Reactive Substances (TBARS) Assay Kit (Cat.# 0801192) was obtained from
ZeptoMetrix Corporation (Buffalo, NY). Total Nitric Oxide Assay Kit (Lot # KGl34678)
was obtained from Thermo Scientific (Rockford, IL). Triton-XlOO was obtained from
Fisher Scientific. Trypan blue solution (0.4%) was obtained from Sigma-Aldrich
(St.Louis, MO). Phosphate buffered saline 10X was obtained from Fisher Scientific.
PTFE cap and target vials were obtained from Fisher scientific. All aqueous solutions
and reagents were prepared in deionized distilled water using ELGA Purelab system from
SIEMIENS.

Cell Culture and Preparation
Endothelial cells are economical alternative, suitable for studies of endothelial
functional and endothelial metabolism. Changes in structure and function of these cells
have been linked to vascular diseases such as atherosclerosis, and hypertension. Human
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coronary artery endothelial cells (HCAEC) used in this study was isolated from normal
human coronary arteries from Cell Application (San Diego, CA). HCAEC were grown in
Mesoendo Cell Growth Medium that is fully supplemented with fetal bovine serum,
growth factors, trace elements and antibiotics. The cells in culture flasks were placed in
an incubator at 37 °C with a humidified atmosphere of 5 % C0 2 . Cells were preserved
and stored with liquid nitrogen in a cryosystem (Cryogenic locator, Thermo).
HCAEC was cultured for treatment when cells are about 80-90% confluent. Cells
were used for all experiments on the passages 5 to 15. Active proliferation cells were
exposed to fine particle or PAHs solutions prepared as described below. After exposure,
cells were harvested from cultured flask. This involves removal of media from flask, a
rinse with Hank's Balanced Salt Solution IX, trysin EDTA IX 0.25 % trypsin/2.21 mM
EDTA in HBSS addition and Mesoendo Cell Growth Medium addition. HCAEC
preparation prior to bioassays involves centrifugation at 1092 rpm (200g), removal
supernatant, followed by HBSS wash twice. Cell count was performed using a
hemacytometer.

Polycyclic Aromatic Hydrocarbons Preparation
EPA method 8310 PAH Mixture was obtained from Restek Corporation.
Acetonitrile with composition of 99.1 % was used as solvent. Certificate of analysis
provided PAH compound and concentration (Appendix D). Ultrasonication was used to
remove air bubbles or to breakup agglomerates before loading 1 ml of the sample into
disposable polystyrene cuvettes. The PAH solution was prepared and diluted
immediately before cell exposure, and diluted as required. Cells were exposed to PAH
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with variable factors of exposure, including the concentration and the duration time of
exposure.

Measurement of Thiobarbituric Acid Reactive Substances
Thiobarbituric acid reactive substances (TBARS) were used as a colorimetric
method to detect malondialdehyde (MD A), an index of lipid peroxidation.
The measured MDA concentration was followed by comparison to linear
regression analysis, and was expressed as MDA equivalents and normalized to total
protein in each sample. In brief, cell homogenization was mixed with the commercially
kit, including butylated hydroxytoluene, thiobarbituric acid and trichloroacetic acid. The
mixture was boiled for 1 hour at 95 ° C, followed by centrifugation after cool down. The
supernatant was measured by a spectrophotometer at the 535 nm. A standard curve was
made based on a series of known MDA concentrations. MDA level was expressed in
nmol/ml/mg after the adjustment of protein concentration.

Protein Measurement
The protein level was estimated by Bradford method using bovine serum albumin
(BSA) as a standard. Dilute the 2 mg/ml BSA standard to make a standard curve from
2.5-2000 ug/ml in 0.05 N NaOH. Add 5 uL of standard, resuspended protein pellet to
each well of a micro plate in duplicate. Add 250 uL of IX coomassie protein assay
reagent to each well of the plate. Incubate at room temperature for at least 5 min. Read
on a micro plate at 600 nm.
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Lipid Extraction
The entire cellular lipids were extracted based on the process that the volumes of
chloroform, methanol and water, before and after dilution, were kept in the proportions of
1:2:0.8 and 2:2:0.8, respectively. The lower chloroform layer containing lipids were
aliquotted as 10% of total sample into glass vials. The vial was placed under a stream of
nitrogen for evaporation and dryness. Briefly, HCAEC were harvested from the flasks
with scraper, and then were transferred and centrifuged for 10 minutes at 1500 rpm. The
supernatant was discarded and the pellet was resuspended in 0.8ml H 2 0. Spin gently to
mix the cell pellet and transfer the mixture to a homogenizer. Cell lipids were
homogenized for a few minutes with 2ml methanol and 1ml chloroform. Then additional
lml chloroform was added and was homogenized for 30s following spinning at a high
speed. After allowing a few minutes for separation and clarification, the alcoholic layer
on the top was removed with long glass pipettes. Remaining chloroform layer containing
the purified lipid were collected and evaporated to dryness under a stream of nitrogen at
room temperature. Lipids were stored at -80 °C if not used immediately.

Lipid Profiling Assessment
A Broker 12 Tesla Apex Qe Fourier Transform Ion Cyclotron Resonance Mass
Spectrometer (12T FT-ICR-MS) at ODU's COSMIC LAB was applied to obtain exact
chemical formulae for organic compounds under 2000Da and to profile lipid distribution.
The high-resolution capability of this instrument offers detection of ions in a wide m/z
range. The ion funnel with the electrospray and nanospray provided both positive and
negative ion runs for identification of polar compounds.
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In this study, the 12 T FT-ICR-MS was performed on the lipid extracts of
HCAEC to demonstrate its lipid profiling capability. The dry lipid sample was prepared
by chloroform and methanol with the extraction method described as above, and then it
was resuspended in running solvent before injecting in the FT-ICR-MS. The solvent of
methanol with 0.1% (v/v) formic acid was used for the positive ion runs, and that of
methanol with 0.1 % (v/v) ammonium hydroxide was for the negative ion runs.
After screening the raw data, spectrum was calibrated and the peaks were
separated to determine molecular mass while molecular formulas were assigned. The
molecular formulas were used to generate the van Krevelen diagram, a two-dimensional
plot, to clarify where the lipids classes were located and to recognize oxidation/reduction
pathways. And then the Matlab program was used to analyze the atoms (C, H, N, O, S,
and P) in negative ion mode and to compare them among treatment groups.
Manipulations were done after importing data into Excel to find out the oxidative effects
of PAH on lipids in endothelial cells.

Measurement of Total Nitric Oxide
Total nitric oxide in the endothelial cells following PAHs exposure was assed
quantitatively using Griess reagent kit (Thermo, KG 134678) (Ghosh et al. 2009). NO
concentration was determined by measuring the content of N0 2 " in cell culture
supernatants, Griess reagents was used for spectrophotometric determination of N02".
Because of the instability of NO in physiological solution, NO oxidizes rapidly to the
mixture of N0 2 " and NO3" in the presence of oxygen. To avoid underestimating NO,
NO3" was converted to NO2" by nitrate reductase, thereby yielding measurement of total
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NO. The colorimetric assay of nitrite (N02")/ nitrate (NO3") provided high sensitivity at
lower Arginine concentrations.
HCAEC were cultured in a 96-well culture plate at a density of 2 x 104cells/ml,
and were treated with 1 ug/ml, and 5 ug/ml PAHs for 0.5 hour incubation. Cell culture
supematants were collected and loaded in a polystyrene black clear bottom 96- well plate
with lOOul/well, followed by 25 ul of diluted NADH and 25 ul of nitrate reductase
enzyme dilution added into each well. The plate was shaking gently to mix well and was
incubated for 0.5 hour at 37 °C with a plate sealer. Then the plate was incubated at room
temperature for 10 minutes after adding 100 ul of Griess reagent into each well. The
reaction produced a chromophore that was measured at 540 nm. The amount of nitrite
accumulated was calculated (in uM) by comparison with standard curve constructed with
known concentrations of sodium nitrite prepared in the cultured medium.

Detection of Endothelial Nitric Oxide Synthase Activity
A fluorimetric cell-associated nitric oxide synthase system was used to detect
NOS activity (Sigma, FCANOSl). The method is based on the principle that a detectable
fluorescent DAF-2T is converted from the non-fluorescence DAF-2DA at the presence of
NOS derived NO. A plate reader at the excitation wavelength of 450-495 nm and an
emission wavelength of 505-550 nm measured the fluorescent product. Relative units
was reported to reflect NOS activity, because most fluoresce is affected by numerous
factors that vary from the environmental conditions of experiments, including excitation
light quality and quantity, instrument geometry and detector characteristics. The NOS
activity was adjusted to the total protein. The protein level and activity of NOS was
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studied simultaneously. A23187, also known as calcium ionophore was used as NOS
stimulator to increase NO production. Diphenyleneiodonium chloride (DPI) was used as
an NOS inhibitor in the positive group to reduce NO generation.

Statistical Analysis
Statistical analysis was performed using Sigma-Plot software. All experiments
were carried out in triplicate, and results were expressed as means ± standard error of the
mean (SEM). Comparisons involving three or more groups were evaluated using oneway ANOVA and an appropriate post hoc comparison. Instances involving only two
comparisons were evaluated with a Student's Mest. Differences among means were
considered statistically significant by the criterion of probability P value < 0.05.
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RESULTS
Lipid peroxidation measurements in HCAEC
Base on the standard curve of MDA, excellent quality control (R2= 0.99) was
generated for the following analysis.
After exposure, MDA was significantly increased in the 1 ug/ml PAHs treated
groups (69.9%,p value = 0.001) after 0.5 hour of treatment as compared to the control
(Figure 22). Moreover, the increase of MDA released from 5 ug/ml PAHs treated
HCAEC was significantly higher than the control (\6l.5%,p < 0.001). However, no
significant difference was observed between 1 and 5 ug/ml PAHs treated groups. From
the results, PAHs induced MDA production in endothelial cells followed a concentrationdependent manner. In addition, increased MDA production in HCAEC had the same
trend with the increase in ROS generation (Figure 23).

Effects of PAHs on NO level
The present study measured the total nitrite as the indicator to estimate the NO
level in HCAEC. Base on the standard curve of nitrite, excellent quality control (R = 1)
was generated for the following analysis.
After exposure, there was an increase in nitrite concentration in the 1 ug/ml PAHs
treated groups (52.7%) after 0.5 hour of treatment as compared to the control (Figure 24).
Moreover, the increase of NO release from treated HCAEC treated by 5 ug/ml PAHs was
significantly higher (74.2%) than the control (p value = 0.003). The increased total nitrite
generation in HCAEC had the same trend with the increase in ROS generation (Figure
25).
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Effects of PAHs on eNOS activity
This study describes comparative in vitro studies of the kinetics patterns of
calcium ionophore (A23187)-stimulated NO release was associated with accelerated
decomposition of NO from the endothelial cells. After control cells incubated with
A23187, a rapid increase of fluorescence reading, 35.1% (p value = 0.01) was observed
in comparison with control group. This result confirmed the stimulating effects of
A23187toeNOS.
1 |J.g/ml of PAHs induced an increase of 12.4% in eNOS activity in HCAEC,
compared to control, while the eNOS activity in 5 and 12 ug/ml of PAHs treated groups
were observed significantly increases with 13.8% and 31.2% (p values were 0.04 and
0.02, respectively). Percentages increase in eNOS activity induced by 5 and 12 ug/ml
PAHs were significantly higher than 1 ug/ml of PAHs treated group (p values were 0.02
and 0.004, respectively). The eNOS activity level observed after incubated with 12
ug/ml of PAHs was significantly higher than 5 ug/ml of PAHs (15.2%, p value was
0.007). Therefore, PAHs modulated eNOS activity in endothelial cells followed a
concentration-dependent manner.
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Effects of PAHs on NO Levels in HCAEC
L-NAME was used as the inhibitor of eNOS. After PAHs exposure, the NO
levels increased in a concentration dependent manner, while the L-NAME decreased the
NO generation in HACEC treated with PAHs. In addition, a significant decrease of NO
was observed in the 5 ug/ml PAHs treated group, which indicating that the L-NAME
modulated eNOS played an important role in regulating the NO level in HCAEC. This
data supported the results generated from the last set of experiment that PAHs activate
eNOS activity in endothelial cells. The altering eNOS activity induced by PAHs is
involved with altering NO bioavailability.
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Figure 27. Effects of L-NAME to HCAEC
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Effects of NADPH on NO Levels in HCAEC
NADPH was used to investigate whether superoxide induced by PAHs is
involved with NO bioavailability. After PAHs exposure, NO levels increased with a
concentration-dependent manner. However, with NADPH exposure, the cells exposed to
both 1 and 5 |Jg/ml PAHs had significantly lower the NO levels as compared to the
control. This result confirmed that superoxide can be generated by PAHs exposure and
directly oxidize NO. At the same time, other mechanisms existed and possibly upregulate eNOS that dominates biological reactions in the cells treated by PAHs. Thus, in
overall, NO levels were increased after PAH exposure.
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Figure 28. Effects of NADPH on HCAEC
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Effects of PAHs to lipid profile in HCAEC
Van krevelen diagram was commonly used as an approach to visalized
complicated mass spectra in the ultrahigh-resolution ESI-MS analyses (Kim et al. 2003).
With this approach, complicated spectra can be plotted in a way that allows for possible
reaction pathways to be identified and qualitative analyses on major classes, such as
lipids. In the present study, van Krevelen diagrams revealed PAH-exposed groups had
cluster molecules, defined as lipids according to the compound classes.
Figure 29 displayed the calibrated mass spectrum of lipids in the control and 1
ug/ml PAHs treated group from negative iron run. Over 600 peaks are detected in the
mass range from 200 to 700 m/z. The lipid extracts may contains other biomaterials or
biodegraded residues, resulting in a multitude of peaks being observed at each nominal
mass (see table 3). The elemental compositions of peaks are calculated from the
corresponding exact mass numbers obtained from the calibrated spectrum, from which, C,
H, O, and N atoms are used to assign the most probable elemental formulas. The
compositions can be assigned with usually < 1 ppm error, and the numbers of atom used
to set during the calibrations are C: 4-65; H: 4-150; O: 0-20; N: 0-4; P: 0-4; S: 0-1. Some
peaks with higher molecular weight, such as over 400 m/z, may have more than one
possible elemental formula. In order to resolve this problem, Kendrick mass defect
analysis was used to determine the assigned elemental formula to make the compound
biological and chemical available, which was done previously (Stenson et al. 2003;
Hughey et al. 2001). To show the complexity of the spectrum, the region of 219-340 m/z
is selected and expanded (Figure 29). Representative peaks of lipids in 1 ug/ml PAHs
treated HCAEC are detected and assigned (Table 3). Therefore, examining individual

peaks in the entire mass range and extracting information, such as the distribution of the
class of the compounds from the spectra, represents a tremendous time and effort
involved.

Table 3. List of representative peaks indentified in the 1 ug/ml PAHs treated HCAEC
Observed
mass, m/z
219.175402
221.154692
227.201675
233.154725
234.186182
235.170223
239.12872
239.165087
239.201475
241.144575
241.180867
241.217275
242.176173
247.170347
249.149563

Proposed mol formula

C
15
14
14
15
15
15
13
14
15
13
14
15
13
16
15

H H+l
23
24
21
22
27
28
21
22
24
25
23
24
19
20
23
24
27
28
21
22
25
26
29
30
24
25
23
24
21
22

N O
0 1
0 2
0 2
0 2
1 1
0 2
0 4
0 3
0 2
0 4
0 3
0 2
1 3
0 2
0 3

S
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

P
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Theoretical
mass, m/z

Difference from thero
value (ppm)

219.175439

-0.2

221.154703

-0.1

227.201654
233.154703

0.1
0.1

234.186338

-0.7

235.170354

-0.6

239.128883

-0.7

239.165268

-0.8

239.201654

-0.7

241.144533

0.2

241.180918

-0.2

241.217304

-0.1

242.176167
247.170354

0
0

249.149618

-0.2
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The van Krevelen diagram of ultrahigh-resolution mass spectrometric data was
plotted using the molar ratio of hydrogen to carbon (H/C) as the y-axis and the molar
oxygen to carbon ratios (O/C) as the x-axis. In the van Krevelen diagram, major
biomaterial classes of compounds locate in specific plot areas on the diagram since they
have their own characteristic H/C and O/C ratios. The lipid data of HCAEC was
displayed and circled in Figure 30. The outliers were possibly derived from noise spikes
in the diagram, or some contamination compounds that remained after lipid extraction.
In the PAHs treated groups, the number of molecules clustered with the mole O/C
and H/C rations between 0 and 0.4, and 1.5 and 2.2, are much higher than that in the
control, indicating that PAHs increased the component numbers of lipids. In the van
Krevelen plot, trend along the line can be used to indicate the structural relationships
among families of compounds generated by reactions that involve loss or gain of
elements in a specific molar ratio (Kim et al. 2003). The plot revealed that PAH
exposure induced various chemical reactions in HCAE. For example, the pink line in
Figure 31 showed the oxidation and/or reduction that occurred after PAH exposure. Also,
the methylation and/or demethylation reaction took place marked as the blue line.
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Since the van Krevenlen diagram failed to demonstrate the oxidative reaction, a
new metric for the degree of oxidation of organic compounds, the average carbon
oxidations state ( OSc) is used, which is a quantity that necessarily increases upon
oxidation and is measurable using FT-ICR-MS. In the present study, the average carbon
oxidations state coupled with carbon numbers (n c) can provide a frame work for
describing the insight into the oxidation. The oxidation state of carbon is defined by the
identity and abundance of non-carbon atoms in the organic compounds; it may be
simplified to

O S c - 2 O/C-H/C

The oxidation state of individual carbon atoms within a molecule may not change in the
same way upon oxidation, but the average oxidation state of the carbon much increase
(Kroll et al. 2011). Therefore, the quantity of average carbon oxidations state is an ideal
metric for the degree of oxidation of lipids in this study.
Figure 32 showed the combinations of average carbon oxidation state and number
of carbon atoms (n c) for lipid molecules in HCAEC. In OSc ~ n c space, lipid oxidation
has an inherent directionality. Since the carbon oxidation state will increase upon
oxidation, the ultimate end product is CO2 ( OSc = +4 ). Reaching this point requires
both the addition of oxygen-containing moieties, which increases average carbon
oxidations state ; and the breaking of C-C bonds, which decreases n c. Thus, the blue
arrows in Figure 33 indicate that the oxidation of HCAEC lipids involves an overall
movement towards the upper right. This figure also represents three key classes of
reactions: functionalization (the oxidative addition of polar functional groups to the
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carbon skeleton), fragmentation (the oxidative cleavage of C-C bonds) and
oligomerization (the association of two organic molecules). Then possible combinations
of average carbon oxidation state and number of carbon atoms for lipid molecules in
Control, 1 and 5 ug/ml PAHs treated HCAEC are compared in figure 33. After PAHs
treatment, more plots are clustered with the -2 < OSc < -1 (Figure 34), however, most
known compounds with higher average oxidation states are small, with 20-40 carbon
atoms.
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Figure 32. Possible combinations of average carbon oxidation state ( OSc) and number
of carbon atoms ( n c ) for lipid molecules in HCAEC.
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DISCUSSION
NO, a major signaling molecule has been shown to associate with oxidative stress
and apoptosis in endothelial cells (Niu et al. 1994). It is also a key regulator of
endothelial function generated by endothelial NO synthase (Forstermann et al. 1993).
Vascular NO could relax blood vessels, prevent platelet aggregation and limit oxidation
of low density lipoprotein cholesterol, decrease the expression of proinflammatory genes
that advance atherogenesis (Forstermann 2008; Forstermann and Munzel 2006). Recent
studies suggested that the toxicity of PAHs may be associated with NO level (Li et al.
2004). The present study documented the results of direct measurement of stimulated
NO release from the HCAEC after short-term treatment with PAHs.
Total nitrite level from the PAHs treated cells was found to be increased than
control. The higher level of NO release was found to be significantly increased after the
treatment with 5 ug /ml of PAHs. NO released from these activated HCAEC along with
the cell damage may thus regulate endothelial function. PAHs increased the NOS
activity after 1 jig/ml, the magnitude of NO release was found to be greatly increased
after 5 and 12 ug/ml concentration. These observations suggest that PAHs treatment
causes eNOS up regulation after a short term exposure. Thus, these data clearly shows
that, following PAHs treatment, eNOS was modulated within HCAEC that results
inalteration of NO production. Similar findings have been reported in two studies that
benzo [ajpyrene, a PAH compound, induced increased NO production in mouse
neuroblastoma cells (Halliwell 2001; Dutta et al. 2010). The study demonstrated that
PAHs induced lipid peroxidation in HCAEC as the evidence by the increased MDA
production. MDA concentrations positively correlated with an increase in ROS
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concentrations. 12T FT-ICR-MS was employed to detect lipids of HCAEC and the van
Krevelen analysis was performed to depict lipid profiling. To our knowledge, this is the
first study to examine the profile of the global lipid distribution in HCAEC in relation to
PAH exposure. Based on the analysis of spectrum data in comparison to untreated
groups, the van Krevelen analysis revealed a significant change in the lipid profile of the
groups exposed to PAHs. The carbon oxidation state was employed to investigate the
oxidation degree from the data of FT-ICR-MS. In the OSc .nc space, oxidation moves
HCAEC lipids upwards and to the right ( OSc = + 4, and n c = 1 ), whereas radical
association reactions in high oxygen environments. The measurement of average carbon
oxidations state allows for the determination of the trajectories for entire lipid mixtures,
offering the potential for lipids.
The number of lipid compounds increased after PAHs exposure, which is likely
resulted from the oxidative stress. The increasing lipid species should be resulted from
unsaturated fatty acyl side chain containing phospholipids, which were oxidized by ROS.
The damage of endothelial cell membrane induced by PAHs may be the other reason to
increase the number of lipid species by fragmentation.
In conclusion, PAHs were a group of components of PM that contributed to
oxidative stress and the dysfunction of endothelial cells. In addition, PAHs contributed
to lipid peroxidation and the changes in the global lipid profile of HCAEC after a short
term exposure. This study has advanced the ability to identify lipids and to develop novel
approaches applicable to large quantity sets of lipid molecular formula data.
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CHAPTER IV
CONCLUSION
Epidemiologic studies have demonstrated a significant association between
exposure to PM and atherosclerosis. Endothelial dysfunction and oxidative stress has
been identified as a common denominator of many cardiovascular risk factors
(Forstermann 2010). Thus, this study has investigated for the first time the role of PAHs
in inducing vascular oxidative stress and endothelial dysfunction in HCAEC.
The findings of this study included the following:
•

PM induced acute cytotoxicity to endothelial cells including change in cellular
morphology, alteration of cellular membrane integrity, and decrease in cellular
viability.

•

PAHs were one of the major components in PM that contributed cytotoxicity to
endothelial cells

•

PAHs could induce a significant increase in ROS concentrations with resulting
oxidative stress to endothelial cells.

•

PAHs induced lipid peroxidation that can cause oxidative degradation of lipids,
resulting in cell damage. .

•

PAHs could alter the lipid profile of HCAEC and increase the number of lipid
species.

•

PAHs altered NO bioavailability by modulating eNOS activity after a short term
exposure.
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CHAPTER V
FUTURE STUDIES
The study showed that PAH induced a significant increase in the number of lipid
specie from the global lipid profiling in HCAEC. The increasing lipid species should be
resulted from unsaturated fatty acyl side chain containing phospholipids, which were
oxidized by ROS. Therefore, the next steps beyond these preliminary data include
identification of specific oxidized lipids, and investigate whether the oxidized lipids
could serve as new candidates for oxidized lipid biomarkers.
In order to conclusively identify the pathway would require further investigation.
The following pathways are considered to influence NO bioavailability as well; however,
the related investigations will be conduct in this future: 1) A potential pathway for
decomposition of NO is the rapid interaction with superoxide anions (O2) to generate an
oxidative stress maker, peroxynitrite (OONO ) (Ignarro 2000). 2) Physical stimuli,
receptor-dependent agonists will affect endothelium derived NO. 3) NO stimulates sGC
that works to produce cGMP. The cGMP accumulation will disturb NO degradation in
smooth muscle cells, and 4) thoroughly examine alteration of NO bioavailability
observed in this study in relation to endothelial dysfunction.
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APPENDIX A
CERTIFIED CONCENTRATIONS FRO SELESTED PAHS IN SRM 2975
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APPENDIX B
REFERENCE CONCENTRATIONS FRO SELECTED PAHS rN SRM 2975

Ma*>$ Fiactsoas

l-Metkdplteaaatkette*^
2-% letlr. Iplieaaatknte^ 4 * r
3.MetMfiteaa»tkeae f " iM ~
4- sad 9-M«hyipi.ea3Ath*ae'*c"5
1 2-D»aed:yfp;iersastfcfeBe ^
16- 1% 25-.22i2
9-Dwxtk}lYhtmmkimetM
1 8-Daueil.sip!ieoasiiiaecetfi
2 6'Dfflwtlylpheaaiitketie*"
2 ^-DaiietMpheaar.titretie *"f
JJ-DtroetliylpbeaaathreBe*'13
Astkacetie*l>s
B«Co[|«lfSaoi aatkeae k
S-M«fn klawaailMietf
1- 3- aad^MetMtlBOfaateae*
2-Mefclpweae sf
4~MefMpyra» tC

Bmm{4$htntthmt]tMl
B«Ho{^]fl'i.a:a8t!'.eae ""
Btttto^jfluoraathate"*^1
Peryieiar^
ladeaotL13<i|p«e«* r *
Mm4l 21< IJfiaota»tbeae>fi
Dtbeaz" yjaatkacene^
Dibeaz^Jaatlinceae TDtbfszf a £]3attaacexse*s,
Peataphene *
BeazefiHItlinseBe*5*
Piceae**8
estrones**
3

0S9
20
10
§44
0 05
0 : -7

=
z
z
z
z
z.
z
z

01*
0 25
02J
018
=
6031 ~
102
0CoS r
r
053
eo+o r
0 022 ±
10
z
00$
s
115
s
0054 z
14
=
1 1
:
0J?
±
0 52
=
0038 z
6 0S z
10
z
*
1 J

011
02
02
009
002
008
002
005
005
002
000$
1*5
0004
003

ooos
0003
04
002
36
0t/»
02
0:
00?
OOS
G&P
COS
02
02

Eadt set of sesu&s » expressed a- t k teferaice valae z tie expadeo uaeatastv Eadi itfereace \ a!«e t$feeaeaa torn oae
analytical twftsd or a man of rt* aeaas f i w i a * or awe arudvhcat methods Fot le-ufe from » o atett»4* lie e«tified
vate a the eqiaS*- -setglreiJ s w a far reads ftoaj feee or a»re iwthodj tte certified vafee n the meaa '\etgited as
descabed -a fade aa2 Muriel [W| Each SBeetaiaty. cotsjtwd according to the C I B I approach as de »cnbed m tte ISO aao
M S I GwJb. [i] r> xi f l a t t e d westatatv at the ^ *s Ir.el of CM JJeiw HIIKII uidtsies MsKfesu -ootces of ttaretatUv
wsfaa each aoahioi isefkrf astf aiitoeg raefbe* as t?eD as tEcenaa"' due to the variation zmor.s tae bottles The
e.\paaded uccertaaly defises a C M ? to* coatasas ±e esamate of lieteas"aloe at a kvel of coaSdeare of appoiaaatel} 95 *«
'" GC MS , l n ea 5 *» pi«ftl-st?o»tm«ei m«JlMpoh^fco.ai,e pla< a f « PFE ttta toSeeae t»tas»l :ia.\tKe
; GC MrS (C) 08 5 c# ptotl-sifeuattei ae-ivtpoi"-jJosace ptee after ?FE w«h DCM
1
GC MS t i l , oa 5 s«phes- J-sitt,tMed tafclpty^feasepifise afterSo-Jie:stracttoa withH2M
' GC MS €\'a) oa ^ r * |,*«R|.4fest«es atettyipohaloaa pha-se a t e PFE tufij DCM
?
GC MS * | \ B oa 50 *»pfcesyvnfeafited iaeiTlpohsski:aK pha^e of--cane rs£a;R as GC MS 0Va)
'5 LC-R of jsoseac PAHfeactoasafter So*MeS oasactism wift DCM
* GC MStll'ckiaaitBecttchfJiJcts^altaepteeofsaatealfaftsai&X M^S-IWi)
8
GC MS (lb) oa 50 % pterri-iftvitated laisvipoksslosajK plase of selered extrar, ±om CC MS {la)

94
APPENDIX C
REFERENCE VALUES FOR PARTICLE-SIZE CHARACTERISTICS FOR SRM 2975

Panicle Me«vi«»eiit

Value''
319
±
112
z
i
I d
OfJS Z

Mean &ameier (volume castrtbwtea MV. net'
Meaa diameter f'area dwnbutjoa paiY*
Meaa dusnetrt ynimfeer ditfubutjaii itnil*'
Ss:£ace AJCS ( m W ) **

06
01
f 04

0 006

Thefellow,wig data s l » v lite percent of the volume tsas n smaller than the 8i4icated ssie
Percentile

55
90
S0

m
60
50 r
40
30
20
10

Panicle Dtamet
<um) w
110
70
44 9
32 4
24 8
19 4
152
11 ?
S5
53

= i
- 2
z 08
= 06
z 04
r 03
= 02
= 02
= 0.1
= 01

•* Each refereace vaSse »the iBeaa •value of raeasuretaejs* t o n tte analysis of ssbsaaiple*fromfear bocles Each aocertaior."
coaipired accsrdm to the CTPM approach as described at tie XIST and ISO Guides [J], is aa exjsac&d tmterfamty at the 95
*»Jr. el of confidence The expanded tincertaintv deiae$ a raare Iwt cowaasp the test e=auaa« of fee trite vatae at afcvelof
raifid«Keofap|»3\jBta?ely3ppfos«»»i\ 9i®<i
The aieaa dtaatetet of tbe voltsae dtsmteaon represents the cesser of pmity of die deiiitatiea aad coayea»ates for
scattermief&ieaca'andKfectr.emdex. Has parameter ts stranger soflueowd by coarse parades
** The ateaa diameter of the area dwribattca calculated Sora tbe Yslome ittBiwaon -mth. less sijflaeace from tl.* presence of
coat ix fMtukt ttea, she MV t a:saetet
* l i e mean diameter of lite auaiSser dsi»t»rioa calculated fraai the t oltsiae ds-m!»aan
* Calculated specific surface area assuming 3 oid spliencal particles This ts a ceaaptaatiea and shoold aot be miereianged «rJi
aa adsorpnoa ate-hed of surface area deterauaaiioa (see TaMe <$* as this rait* does so? reflect poro-ity or topoaapliical
charaetenMies
f
Medtaa i J i w u %ik>*s of the selatte is less taaa 1$ 4 am)

95
APPENDIX D
CERTIFICATE OF EPA METHOD 8310 PAH MIXTURE
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APPENDIX E
LIST OF ABBREVIATIONS
Abbreviations

The full names

A23187

Calcium ionosphore

ANOVA

Analysis of variance

BSA

Bovine serum albumin

Carboxy-H2DFFDA

5-(and-6)-carboxy-2', T- difluorodihydrofluorescein diacetate

cGMP

3', 5'- guanosine monophosphate

CVDs

Cardiovascular diseases

DAF-2DA

4, 5 Diaminofluorescein diacetate

DAF-2T

Triazolofluorescein

DCF

T, 7'-dichlorodihydrofluorescein

DFF

2', T- difluorodihydrofluorescein

DMSO

Dimethyl sulfoxide

DLS

Dynamic light scattering

DPI

Diphenyleneiodonium chloride

DPM

Diesel particulate matter

EDRF

Endothelium-derived relaxing factor

EDTA

Ethylenediaminetetraacetic acid

EGTA

Ethylene glycol tetraacetic acid

eNOS

Endothelial nitric oxide synthase
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LIST OF ABBREVIATIONS
FBS

Fetal bovine serum

Fe 2 +

Ferrous iron

Fe 3 +

Ferric iron

FMD

Flow-medicated dilation

FT-ICR-MS

Fourier transform ion cyclotron resonance mass spectrometry

ET-1

Endothelin -1

HBSS

Hank's Buffered Salt Solution

HCAEC

Human coronary artery endothelial cells

H2DCFDA

2', 7'-dichlorodihydrofluorescein diacetate

H2DFFDA

2', 7'- difluorodihydrofluorescein diacetate

H202

Hydrogen peroxide

iNOS

Inducible nitric oxide synthase

IL-IB

Interleukin-IB

IL-6

Interleukin-6

IL-8

Interleukin-8

LDH

Lactate dehydrogenase

L-NAME

Nw-nitro-L-arginine methyl ester hydrochloride

LPO

Lipid peroxidation

MDA

Malondialdehyde
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LIST OF ABBREVIATIONS
NFKB

Nuclear factor kappa-B

nNOS

Neuronal nitric oxide synthase

NO

Nitric Oxide

NO2"

Nitrite

NO3"

Nitrate

ONOO"

Peroxynitrite

oxLDL

Oxidative low-density lipoprotein

PAHs

Poly-aromatic Hydrocarbons

PM

Particulate matters

PM 25

Particulate matter with diameter under 2.5 um

PM10

Particulate matter with diameter under 10 um

PUFA

Polyunsaturated fatty acid

ROS

Reactive oxygen species

SEM

Standard error of the mean

SEM-EDS

Scanning Electron Microscopy- Energy Dispersive Spectroscopy

TBARS

Thiobarbituric acid reactive substances

UFP

Ultrafine particle, particulate matter with diameter under 0.1 urn
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